Ivermectin scabies

The agent of choice for scabies is permerthrin 5% (Elimite) cream. Alternative agents in subjects who cannot use permethrin are crotamiton 10% (Eurax) and oral ivermectin (Stromectal) 200 mcg/kg as a single dose. To initiate the treatment with permerthrin, the skin should be scrubbed in a warm soapy bath to remove the scabs. The permerthrin lotion should then be applied to the whole body, avoiding the face, mucous membranes, and eyes, and left on for 8 to 14 hours. A single application eradicates 97% of scabies. All close contacts should be treated appropriately. The pruritus associated with scabies may persist for 2 to 4 weeks because of the remnants of mite parts in the skin. 

Scabies fSareopies cobieij Permethrin dermal cream. In retlsiani cases consider monosulfiram or benzyl benzoate. Alternative ivermectin (single dose) especially for outbreaks in dosed communities. Crocamiton or calamine for residual itch. Apply to all members of the household, immediate family or partner Change underclothes and bedclothes after application. 

Ivermectin, a dihydroavermectin Bl, is an effective microfilaricide used in the treatment of strongyloides, scabies, and aU types of filariasis except Dipalonema (Mansonelta) perstans infections. 

In a randomized trial a single oral dose of ivermectin (200 micrograms/kg) has been compared with 1% gamma-benzene hexachloride lotion for topical application overnight in 200 patients with scabies (16). The patients were assessed after 48 hours, 2 weeks, and 4 weeks. After 4 weeks, 83% showed marked improvement with ivermectin, compared with 44% of those treated with gamma-benzene hexachloride. There were no adverse events reported with gamma-benzene hexachloride. Headache was reported only once with ivermectin. 

In 80 children aged 6 months to 14 years a single dose of ivermectin 200 micrograms/kg was compared with topical benzyl benzoate for the treatment of pediatric scabies in a randomized, controlled trial (17). Ivermectin cured 24 of 43 patients and topical benzyl benzoate cured 19 of 37 patients at 3 weeks after treatment. There were no serious adverse effects with either treatment, although benzyl benzoate was more likely to produce local skin reactions. These results are in line with those of another study, in which 18 children aged 14 months to 17 years with either scabies (n — 11) or cutaneous larva migrans (n — 7) were... 

A puzzling reaction was recorded in a small hospitalized Canadian population of elderly subjects treated for scabies with a single dose of ivermectin (150-200 micrograms/kg). Within 6 months, 15 of the 47 patients had died. All those who died had developed a sudden change in behavior, with lethargy, anorexia, and listlessness before death (31). The effect may have been an artefact with some extraneous cause, and it is notable that other groups using this treatment for scabies have not recorded similar reactions. 

Jaramillo-Ayerbe F, Berrio-Munoz J. Ivermectin for crusted Norwegian scabies induced by use of topical steroids. Arch Dermatol 1998 134(2) 143-5. 

Paasch LF, Haustein UF. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol 2000 39(6) 463-70. 

Madan V, Jaskiran K, Gupta U, Gupta DK. Oral ivermectin in scabies patients a comparison with 1% topical lindane lotion. J Dermatol 2001 28(9) 481-4. 

Brooks PA, Grace RF. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries. J Paediatr Child Health 2002 38(4) 401. ... 

Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 1997 349(9059) 1144-5. 

Other agents used to treat scabies are Crotamiton 10% (Eurax) and oral ivermectin (Stromectal) 200 mcg/kg once. These should be used in patients who have hypersensitivity to permethrin preparations. Topical corticosteroids and antihistamines may be used... 

Analogous to the derivation of Synercid from a veterinary antibiotic, another famous example of the use of a modified veterinary product in man as an antiparasitic is the oral use of ivermectin (Mectizan, Stromectol) (42a (80%), 42b (20%) Figure 9) in the treatment of strongyloidiasis, onchocerciasis (river blindness), and for the treatment of filariasis. In addition to these uses (predominately in Africa), in 2006 Banyu received approval of the product in Japan for the treatment of scabies. ... 

Ivermectin (Stromectol), an anthelmintic drug used traditionally to treat onchocerciasis, also is effective in the off-label treatment of scabies. 

Preliminary studies indicated that ivermectin has the potential to be the drug of choice for ectoparasitic infestations (mites, lice) of humans as well. Recently, there is growing evidence that scabies can also be treated by oral administration of ivermectin. Treatment of scabies is very difficult, and relapse is frequent after topical scabicidal therapy. Ivermectin has been proven to be a safe and effective alternative for the therapy of severe Sarcoptes scabiei infestation unresponsive to conventional treatment. 

The efficacy of ivermectin for human onchocerciasis was established in the 1980s and is summarized in this chapter briefly. Clinical study of ivermectin in human strongyloidiasis has not yet been completed. Here we describe the efficacy of ivermectin for human strongyloidiasis as observed in our institution during the past decade. Furthermore, we would like to describe the combination therapy with ivermectin and albendazole for bancroftian filariasis and also the efficacy of ivermectin in the treatment of human scabies. 

Macotela-Ruiz, E., and Pena-Gonzalez, G. (1993). The treatment of scabies with oral ivermectin. Gac. Med. Mex. 129, 201-205. 

Taken as a single 200- ig/kg oral dose, ivermectin is a first-line drug for treatment of cutaneous larva migrans. Similar doses also are safe and highly effective against human head lice and scabies, even in HIV-infected individuals. 

Because ivermectin does not cross the blood-brain barrier, there is no major CNS toxicity. Ivermectin, available as a 6-mg tablet, is given at a dose of 250-400 /ig/kg, which is repeated in a week. Cure rates of 70% after one dose and 95% after two doses given 2 weeks apart have been achieved. For treatment of scabies outbreaks in large groups, this drug has obvious advantages as compared with topical therapy. 

Chosidow O, Green MS, Hengge UR, and 137 other authors. Permethrin and ivermectin for scabies. N Engl J Med 2010 362 717-25. 

The scabies mite, Sarcoptes scabiei van hominis, is becoming increasingly resistant to existing acaricidal compounds such as lindane, benzyl benzoate, permethrin, and oral ivermectin. The potential use of a 5% M. alternifolia essential oil solution to treat scabies infections was investigated in vitro. It was found to be highly effective at reducing mite survival times, and the main active component was terpinen-4-ol. However, the in vivo effectiveness was only tested on one individual, in combination with benzyl benzoate and ivermectin (Walton et al., 2004). 

Observational studies The use of oral ivermectin has been evaluated in eight Egyptian patients with crusted scabies who took a single oral dose of ivermectin 200 micrograms/ kg and were re-examined at 2, 4, 6, and 8 weeks [10 ]. A second dose of ivermectin was given if there was treatment failure at the end of the second week, and a third dose... 

Nofal A. Variable response of crusted scabies to oral ivermectin report on eight Egyptian patients. J Eur Acad Dermatol Venereol 2009 23 793-7. 

---